Marex
MRX

Marex (MRX) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
William BlairInitiated CoverageOutperform—Oct 14, 2026
BarclaysMaintainedOverweight$92.00 from $86.00Oct 7, 2026
Piper SandlerMaintainedOverweight$80.00 from $75.00Oct 2, 2026
Keefe, Bruyette & WoodsMaintainedOutperform$90.00 from $80.00Aug 13, 2026
BarclaysMaintainedOverweight$86.00 from $76.00Aug 13, 2026
UBSMaintainedBuy$90.00 from $82.00Aug 13, 2026
JefferiesMaintainedBuy$80.00 from $57.00Jul 20, 2026
Piper SandlerMaintainedOverweight$75.00 from $55.00Jul 15, 2026
Keefe, Bruyette & WoodsMaintainedOutperform$80.00 from $60.00Jul 10, 2026
BarclaysMaintainedOverweight$76.00 from $60.00Jul 9, 2026
TD CowenMaintainedBuy$75.00 from $67.00Jun 8, 2026
BarclaysMaintainedOverweight$60.00 from $55.00May 11, 2026
TD CowenMaintainedBuy$67.00 from $66.00May 7, 2026
Keefe, Bruyette & WoodsMaintainedOutperform$60.00Apr 8, 2026
UBSMaintainedBuy$60.00 from $56.00Apr 2, 2026
BarclaysMaintainedOverweight$55.00 from $50.00Mar 27, 2026
TD CowenMaintainedBuy$66.00 from $61.00Mar 27, 2026
BarclaysMaintainedOverweight$50.00 from $49.00Mar 4, 2026
Piper SandlerMaintainedOverweight$55.00 from $50.00Jan 14, 2026
TD CowenMaintainedBuy$61.00 from $54.00Jan 14, 2026

Frequently asked questions

  • What is the latest analyst rating on MRX?

    On Oct 14, 2026, William Blair initiated coverage of Marex at Outperform.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.